Ntanasis-Stathopoulos, I.; Filippatos, C.; Malandrakis, P.; Koutoulidis, V.; Kastritis, E.; Terpos, E.; Dimopoulos, M.-A.; Gavriatopoulou, M.
Upfront Anti-CD38 Monoclonal Antibody-Based Quadruplet Therapy for Multiple Myeloma: A Systematic Review and Meta-Analysis of Clinical Trials. Cancers 2025, 17, 1943.
https://doi.org/10.3390/cancers17121943
AMA Style
Ntanasis-Stathopoulos I, Filippatos C, Malandrakis P, Koutoulidis V, Kastritis E, Terpos E, Dimopoulos M-A, Gavriatopoulou M.
Upfront Anti-CD38 Monoclonal Antibody-Based Quadruplet Therapy for Multiple Myeloma: A Systematic Review and Meta-Analysis of Clinical Trials. Cancers. 2025; 17(12):1943.
https://doi.org/10.3390/cancers17121943
Chicago/Turabian Style
Ntanasis-Stathopoulos, Ioannis, Charalampos Filippatos, Panagiotis Malandrakis, Vassilis Koutoulidis, Efstathios Kastritis, Evangelos Terpos, Meletios-Athanasios Dimopoulos, and Maria Gavriatopoulou.
2025. "Upfront Anti-CD38 Monoclonal Antibody-Based Quadruplet Therapy for Multiple Myeloma: A Systematic Review and Meta-Analysis of Clinical Trials" Cancers 17, no. 12: 1943.
https://doi.org/10.3390/cancers17121943
APA Style
Ntanasis-Stathopoulos, I., Filippatos, C., Malandrakis, P., Koutoulidis, V., Kastritis, E., Terpos, E., Dimopoulos, M.-A., & Gavriatopoulou, M.
(2025). Upfront Anti-CD38 Monoclonal Antibody-Based Quadruplet Therapy for Multiple Myeloma: A Systematic Review and Meta-Analysis of Clinical Trials. Cancers, 17(12), 1943.
https://doi.org/10.3390/cancers17121943
